agilon health, inc. reports results for the quarter ended September 30 - Earnings Summary
agilon health, inc. reports results for the quarter ended September 30 - Earnings Summary
agilon health, inc. AGL.N reported quarterly adjusted earnings of $1.97 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-6.75. The mean expectation of fifteen analysts for the quarter was for a loss of $1.19 per share. Wall Street expected results to range from $-1.83 to -28 cents per share.
Revenue rose 5.9% to $1.52 billion from a year ago; analysts expected $1.46 billion.
agilon health, inc.'s reported EPS for the quarter was $1.97.
The company reported quarterly net income of $34.91 million.
agilon health, inc. shares had risen by 10.3% this quarter and gained 409.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 4.9% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for agilon health, inc. is $115.00, about 16.3% above its last closing price of $96.23
This summary was machine generated from LSEG data November 4 at 11:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | -1.19 | 1.97 | Beat |
Jun. 30 2026 | -0.10 | 1.04 | Beat |
Mar. 31 2026 | 0.94 | 1.80 | Beat |
Dec. 31 2025 | -6.72 | -11.50 | Missed |
Recent news on agilon health
See all newsUS RESEARCH ROUNDUP-Cencora, Dave, Uber
agilon health, inc. reports results for the quarter ended September 30 - Earnings Summary
Agilon Health Q3 revenue beats estimates, raises FY guidance
Brief: Agilon Health Q3 Revenue USD 1,520 Million Vs. IBES Estimate USD 1,461 Million
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla